Notify me when Frankenius Equity AB files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| TLSI | TriSalus Life Sciences, Inc. | Common Stock, $0.0001 par value | 14% | $34,179,868 | $1,257,864 | 6,989,748 | +3.8% | Frankenius Equity AB | 31 Jul 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|